skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Springer Nature - Springer Journals All 2022 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies
Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies

Einarsson, Jon Thorkell ; Evert, Max ; Geborek, Pierre ; Saxne, Tore ; Lundgren, Maria ; Kapetanovic, Meliha C

Clinical rheumatology, 2017-12, Vol.36 (12), p.2743-2750 [Periódico revisado por pares]

London: Springer London

Texto completo disponível

Citações Citado por
2
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

Zéphir, Hélène ; Bernard-Valnet, Raphaël ; Lebrun, Christine ; Outteryck, Olivier ; Audoin, Bertrand ; Bourre, Bertrand ; Pittion, Sophie ; Wiertlewski, Sandrine ; Ouallet, Jean Christophe ; Neau, Jean-Philippe ; Ciron, Jonathan ; Clavelou, Pierre ; Marignier, Romain ; Brassat, David

Journal of neurology, 2015-10, Vol.262 (10), p.2329-2335 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
3
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
Material Type:
Artigo 		Adicionar ao Meu Espaço

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

Loarce-Martos, Jesús ; García-Fernández, Antía ; López-Gutiérrez, Fernando ; García-García, Verónica ; Calvo-Sanz, Laura ; del Bosque-Granero, Iván ; Terán-Tinedo, M. Andreína ; Boteanu, Alina ; Bachiller-Corral, Javier ; Vázquez-Díaz, Mónica

Rheumatology international, 2020-12, Vol.40 (12), p.2015-2021 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
4
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

A comprehensive review of rituximab therapy in rheumatoid arthritis patients

Tavakolpour, Soheil ; Alesaeidi, Samira ; Darvishi, Mohammad ; GhasemiAdl, Mojtaba ; Darabi-Monadi, Sahar ; Akhlaghdoust, Meisam ; Elikaei Behjati, Somayeh ; Jafarieh, Arash

Clinical rheumatology, 2019-11, Vol.38 (11), p.2977-2994 [Periódico revisado por pares]

London: Springer London

Texto completo disponível

Citações Citado por
5
Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus
Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus

Kang, Cho Eun ; Lee, Seungeun ; Seo, Dong Hye ; Heo, Woon ; Kwon, Sun Hyung ; Kim, JeongRyeol ; Lee, Jinu ; Ko, Byoung Joon ; Koiwa, Hisashi ; Kim, Woo Taek ; Kim, Joo Young

Molecular biotechnology, 2021-11, Vol.63 (11), p.1016-1029 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
6
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study

Shaygannejad, V. ; Fayyazi, E. ; Badihian, S. ; Mirmosayyeb, O. ; Manouchehri, N. ; Ashtari, F. ; Asgari, N.

Journal of neurology, 2019-03, Vol.266 (3), p.642-650 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study
Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness and safety of orelabrutinib with rituximab and lenalidomide in low KPS score and elderly patients with newly diagnosed primary central nervous system lymphoma—a single-center retrospective study

Guo, Xiao-Ling ; Zhao, Zi-Yu ; Guo, Xue-Fei ; Zuo, Ya-Bei ; Li, Jin-Ao ; Nie, Zi-Yuan ; Ren, Jin-Hai

Neurological sciences, 2024-06, Vol.45 (6), p.2931-2934 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
8
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial

Adams, H ; van de Garde, E M W ; Vugts, D J ; Grutters, J C ; Oyen, Wim J G ; Keijsers, R G

2023-06

Texto completo disponível

Citações Citado por
9
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

Muylle, Kristoff ; Flamen, Patrick ; Vugts, Danielle J ; Guiot, Thomas ; Ghanem, Ghanem ; Meuleman, Nathalie ; Bourgeois, Pierre ; Vanderlinden, Bruno ; van Dongen, Guus A M S ; Everaert, Hendrik ; Vaes, Mélanie ; Bron, Dominique

European journal of nuclear medicine and molecular imaging, 2015-07, Vol.42 (8), p.1304-1314 [Periódico revisado por pares]

Germany

Texto completo disponível

Citações Citado por
10
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study

Li, Wenqi ; Chang, Yu ; Liu, Xiyang ; Chen, Ziqi ; Sun, Jinmiao ; Geng, Zurui ; Zhang, Mingzhi ; Zhang, Lei

Annals of hematology, 2024-06, Vol.103 (6), p.2003-2012 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (2.193)
  2. Revistas revisadas por pares (2.131)

Data de Publicação 

De até
Refinar
  1. Antes de2002  (30)
  2. 2002Até2006  (160)
  3. 2007Até2011  (482)
  4. 2012Até2017  (693)
  5. Após 2017  (835)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.048)
  2. Japonês  (215)
  3. Alemão  (151)
  4. Norueguês  (2)
  5. Italiano  (1)
  6. Chinês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.